News

Fierce Healthcare3d
Hims & Hers' Q1 revenue doubles to $586M, boosted by growth in weight loss business
But Hims & Hers' shares fell in after-hours trading as second-quarter projections fell short of analysts' expectations. The ...
Healio7d
GLP-1 agents ‘can help lower systemic inflammation,’ show promise in rheumatology
The apparent success — and now almost ever-present ubiquity — of GLP-1 receptor agonists in weight loss has led to research, and possible uses, far beyond its initial indications in diabetes, ...
WHO set to back use of weight-loss drugs for adults globally, raises cost issue
LONDON - The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for ...
Medical Dialogues4d
WHO to back use of weight-loss drugs as obesity treatment in adults
London: The World Health Organization (WHO) is set to officially back the use of weight-loss drugs as a treatment for obesity ...
Novo Nordisk teams with telehealth firms Him, Ro to sell Wegovy at lower price
Hims and Hers Health Inc. soared in pre-market trading after Novo Nordisk A/S said it would sell its popular weight-loss drug ...
Zacks.com on MSN1d
Novo Nordisk Q1 Earnings Match Estimates, Revenues Rise Y/Y, Stock Up
NVO stock gains after reporting first-quarter 2025 results, mainly due to expectations of U.S. sales recovery of its popular ...
Exclusive-WHO to back use of weight-loss drugs for adults globally, raises cost issue
LONDON (Reuters) -The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in ...